:: Farmabrasilis Português Inglês Home | Site Map | Add to Favorites Link | Send page to a Friend | Contact us
Site Search
Todos os Conteúdos


Animal models of cancer - Walker 256 carcinosarcoma

Effect of P-MAPA on Walker 256- A tumor in Wistar rats


Walker 256 -A tumor: Walker 256-A tumor is known by their growth capacity and lethality after a single subcutaneous (sc) injection in Wistar rats.

Lethality is associated to the severe homeostatic disturbances induced by the W256 -A tumor, which includes anorexia, thymus atrophy and hydro electrolyte disturbances with glomerular filtration and tubular function alterations (Guimarães F.et al, 2010)

Experimental design: two groups of Wistar rats (eight animals each) were inoculated with 4x106 cells Walker 256 A tumor (variant A tumor) and treated subcutaneously with daily doses of 0.5 and 1 mg/kg P-MAPA, beginning 24 h after tumor inoculation. Control animals inoculated with 4x106 cells Walker 256- A tumor (n=8) received only saline.

Evaluation of tumoral growth: the development of tumors was evaluated every two days by percutaneous measurements in two dimensions (axial and perpendicular) with a digital caliper. The values in Figure 2 represent the average diameter of tumors of each group of eight animals.

Results: P-MAPA significantly inhibited tumor growth and survival compared with the untreated tumor-bearing animals, which died within 27 days.

In addition, 50% (4/8 animals) and 37.5% (3/8 animals) of animals treated with 0.5 mg/kg and 1 mg/kg with P-MAPA, respectively, exhibited complete tumor regression and enhanced survival rate (Figure 1 and Figure 2).


Of note, mice cured of Walker 256 by MAPA treatment were largely resistant to rechallenge with Walker 256, suggesting a role for T lymphocytes (21). 


Figure 1


Figure 2


* Published at Int. J. Mol. Med.1999, 4 , S49 

Indique a um Amigo Indique a um Amigo ImprimirImprimir VoltarVoltar
Lógica Digital
Privacy Policy  |  Legal  |  [email protected] all rights reserved